サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1412529

ヘルペスマーカー検査市場：適応症、検査タイプ、用途別-世界予測2024-2030年

Herpes Marker Testing Market by Indication (HSV-1, HSV-2), Test Type (Antibody or Antigen-based Kits, Nucleic Acid Amplification based Kits, Viral Culture Test), Application - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ヘルペスマーカー検査市場：適応症、検査タイプ、用途別-世界予測2024-2030年
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヘルペスマーカー検査市場規模は、2023年に4億6,822万米ドルと推定され、2024年には4億9,786万米ドルに達し、CAGR 6.46%で2030年には7億2,583万米ドルに達すると予測されています。

ヘルペスマーカー検査の世界市場

主な市場の統計
基準年[2023］ 4億6,822万米ドル
予測年[2024] 4億9,786万米ドル
予測年 [2030] 7億2,583万米ドル
CAGR（%） 6.46%
ヘルペスマーカー検査 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはヘルペスマーカー検査市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、ヘルペスマーカー検査市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-ヘルペスマーカー検査市場の市場規模および予測は？

2-ヘルペスマーカー検査市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-ヘルペスマーカー検査市場における技術動向と規制の枠組みは？

4-ヘルペスマーカー検査市場における主要ベンダーの市場シェアは？

5-ヘルペスマーカー検査市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 集団内のヘルペス感染症の有病率
      • 口腔および性器感染症の早期診断と治療に対する意識の高まり
      • ヘルスケア支出の増加とヘルスケアインフラの改善
    • 抑制要因
      • 熟練した人材が不足しているため、利用できる研究所が限られている
    • 機会
      • 新開発のヘルペス検査キットのイントロダクション
      • ヘルペス感染症を治療するための新しいワクチンの調査活動が拡大
    • 課題
      • 厳格で時間のかかる承認プロセス
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 ヘルペスマーカー検査市場適応症別

  • HSV-1
  • HSV-2

第7章 ヘルペスマーカー検査市場テストタイプ別

  • 抗体または抗原ベースのキット
  • 核酸増幅ベースのキット
  • ウイルス培養検査

第8章 ヘルペスマーカー検査市場：用途別

  • 臨床
  • 調査

第9章 南北アメリカのヘルペスマーカー検査市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のヘルペスマーカー検査市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのヘルペスマーカー検査市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • Abcam PLC
    • AdvaCare Pharma
    • Bio-Diagnostics Ltd.
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Biopanda Reagents Ltd.
    • CTK Biotech, Inc.
    • DiaSorin S.p.A.
    • F. Hoffmann-La Roche Ltd.
    • Genome Diagnostics Pvt. Ltd.
    • Hologic, Inc.
    • InTec PRODUCTS, INC.
    • Merck KGaA
    • Meridian Bioscience, Inc. by SD Biosensor, Inc.
    • Norgen Biotek Corporation
    • QED Bioscience, Inc.
    • Qiagen N.V.
    • Quidel Corporation
    • Rapid STD Testing by RSC Health, PA
    • Teco Diagnostics
    • Thermo Fisher Scientific, Inc.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. HERPES MARKER TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. HERPES MARKER TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. HERPES MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. HERPES MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. HERPES MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HERPES MARKER TESTING MARKET DYNAMICS
  • FIGURE 7. HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 10. HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. HERPES MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. HERPES MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. HERPES MARKER TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. HERPES MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 6. HERPES MARKER TESTING MARKET SIZE, BY HSV-1, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. HERPES MARKER TESTING MARKET SIZE, BY HSV-2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. HERPES MARKER TESTING MARKET SIZE, BY ANTIBODY OR ANTIGEN-BASED KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. HERPES MARKER TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION BASED KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. HERPES MARKER TESTING MARKET SIZE, BY VIRAL CULTURE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. HERPES MARKER TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. HERPES MARKER TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. HERPES MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 143. HERPES MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. HERPES MARKER TESTING MARKET LICENSE & PRICING
目次
Product Code: MRR-DD0700E81D13

[194 Pages Report] The Herpes Marker Testing Market size was estimated at USD 468.22 million in 2023 and expected to reach USD 497.86 million in 2024, at a CAGR 6.46% to reach USD 725.83 million by 2030.

Global Herpes Marker Testing Market

KEY MARKET STATISTICS
Base Year [2023] USD 468.22 million
Estimated Year [2024] USD 497.86 million
Forecast Year [2030] USD 725.83 million
CAGR (%) 6.46%
Herpes Marker Testing Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Herpes Marker Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Herpes Marker Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Herpes Marker Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, AdvaCare Pharma, Bio-Diagnostics Ltd., Bio-Rad Laboratories, Inc., bioMerieux SA, Biopanda Reagents Ltd., CTK Biotech, Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Genome Diagnostics Pvt. Ltd., Hologic, Inc., InTec PRODUCTS, INC., Merck KGaA, Meridian Bioscience, Inc. by SD Biosensor, Inc., Norgen Biotek Corporation, QED Bioscience, Inc., Qiagen N.V., Quidel Corporation, Rapid STD Testing by RSC Health, PA, Teco Diagnostics, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Herpes Marker Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • HSV-1
    • HSV-2
  • Test Type
    • Antibody or Antigen-based Kits
    • Nucleic Acid Amplification based Kits
    • Viral Culture Test
  • Application
    • Clinical
    • Research
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Herpes Marker Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Herpes Marker Testing Market?

3. What are the technology trends and regulatory frameworks in the Herpes Marker Testing Market?

4. What is the market share of the leading vendors in the Herpes Marker Testing Market?

5. Which modes and strategic moves are suitable for entering the Herpes Marker Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Herpes Marker Testing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of herpes infections among population
      • 5.1.1.2. Growing awareness of early diagnosis and treatments of oral and genital infection
      • 5.1.1.3. Rising healthcare spendings and improved healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of laboratories along with lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of newly developed herpes testing kits
      • 5.1.3.2. Growing research activities for novel vaccines to treat herpes infections
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent and time consuming approval processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Herpes Marker Testing Market, by Indication

  • 6.1. Introduction
  • 6.2. HSV-1
  • 6.3. HSV-2

7. Herpes Marker Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Antibody or Antigen-based Kits
  • 7.3. Nucleic Acid Amplification based Kits
  • 7.4. Viral Culture Test

8. Herpes Marker Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical
  • 8.3. Research

9. Americas Herpes Marker Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Herpes Marker Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Herpes Marker Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abbott Laboratories
    • 13.1.2. Abcam PLC
    • 13.1.3. AdvaCare Pharma
    • 13.1.4. Bio-Diagnostics Ltd.
    • 13.1.5. Bio-Rad Laboratories, Inc.
    • 13.1.6. bioMerieux SA
    • 13.1.7. Biopanda Reagents Ltd.
    • 13.1.8. CTK Biotech, Inc.
    • 13.1.9. DiaSorin S.p.A.
    • 13.1.10. F. Hoffmann-La Roche Ltd.
    • 13.1.11. Genome Diagnostics Pvt. Ltd.
    • 13.1.12. Hologic, Inc.
    • 13.1.13. InTec PRODUCTS, INC.
    • 13.1.14. Merck KGaA
    • 13.1.15. Meridian Bioscience, Inc. by SD Biosensor, Inc.
    • 13.1.16. Norgen Biotek Corporation
    • 13.1.17. QED Bioscience, Inc.
    • 13.1.18. Qiagen N.V.
    • 13.1.19. Quidel Corporation
    • 13.1.20. Rapid STD Testing by RSC Health, PA
    • 13.1.21. Teco Diagnostics
    • 13.1.22. Thermo Fisher Scientific, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing